Establishing Novel Imaging Biomarkers of ADPKD to Identify Rapidly Progressive Patients

Time: 12:00 pm
day: Track 1 - Day 1 AM


  • Optimizing total kidney volume (TKV) to accurately predict eGFR decline
  • Uncovering opportunities to identify treatable patients with ADPKD earlier in disease progression
  • Negotiating challenges in TKV from the payer to the regulator